8-100220270-C-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003114.5(SPAG1):c.1536-9C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00387 in 1,597,254 control chromosomes in the GnomAD database, including 188 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.020   (  103   hom.,  cov: 33) 
 Exomes 𝑓:  0.0021   (  85   hom.  ) 
Consequence
 SPAG1
NM_003114.5 intron
NM_003114.5 intron
Scores
 2
 Splicing: ADA:  0.00006279  
 2
Clinical Significance
Conservation
 PhyloP100:  0.266  
Publications
1 publications found 
Genes affected
 SPAG1  (HGNC:11212):  (sperm associated antigen 1) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm agglutinating antibodies from an infertile woman. Furthermore, immunization of female rats with the recombinant human protein reduced fertility. This protein localizes to the plasma membrane of germ cells in the testis and to the post-acrosomal plasma membrane of mature spermatozoa. Recombinant polypeptide binds GTP and exhibits GTPase activity. Thus, this protein may regulate GTP signal transduction pathways involved in spermatogenesis and fertilization. Two transcript variants of this gene encode the same protein. [provided by RefSeq, Jul 2008] 
SPAG1 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 28Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56). 
BP6
Variant 8-100220270-C-G is Benign according to our data. Variant chr8-100220270-C-G is described in ClinVar as Benign. ClinVar VariationId is 416531.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0675  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SPAG1 | ENST00000388798.7 | c.1536-9C>G | intron_variant | Intron 12 of 18 | 1 | NM_003114.5 | ENSP00000373450.3 | |||
| SPAG1 | ENST00000251809.4 | c.1536-9C>G | intron_variant | Intron 12 of 18 | 5 | ENSP00000251809.3 | ||||
| SPAG1 | ENST00000523302.1 | n.343-4903C>G | intron_variant | Intron 1 of 2 | 3 | 
Frequencies
GnomAD3 genomes  0.0202  AC: 3069AN: 152140Hom.:  101  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3069
AN: 
152140
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00578  AC: 1352AN: 233780 AF XY:  0.00432   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1352
AN: 
233780
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00214  AC: 3094AN: 1444996Hom.:  85  Cov.: 31 AF XY:  0.00187  AC XY: 1341AN XY: 718814 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
3094
AN: 
1444996
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
1341
AN XY: 
718814
show subpopulations 
African (AFR) 
 AF: 
AC: 
2227
AN: 
32206
American (AMR) 
 AF: 
AC: 
212
AN: 
39170
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
62
AN: 
25144
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39570
South Asian (SAS) 
 AF: 
AC: 
23
AN: 
83074
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53172
Middle Eastern (MID) 
 AF: 
AC: 
21
AN: 
5680
European-Non Finnish (NFE) 
 AF: 
AC: 
243
AN: 
1107322
Other (OTH) 
 AF: 
AC: 
306
AN: 
59658
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.471 
Heterozygous variant carriers
 0 
 125 
 250 
 374 
 499 
 624 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 80 
 160 
 240 
 320 
 400 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0203  AC: 3085AN: 152258Hom.:  103  Cov.: 33 AF XY:  0.0195  AC XY: 1453AN XY: 74446 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3085
AN: 
152258
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
1453
AN XY: 
74446
show subpopulations 
African (AFR) 
 AF: 
AC: 
2890
AN: 
41536
American (AMR) 
 AF: 
AC: 
116
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
7
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5188
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10604
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
42
AN: 
68010
Other (OTH) 
 AF: 
AC: 
27
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 134 
 268 
 401 
 535 
 669 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 36 
 72 
 108 
 144 
 180 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
27
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:5 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Primary ciliary dyskinesia 28    Benign:3 
Oct 14, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 21, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 09, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Benign 
 dbscSNV1_RF 
 Benign 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.